Pipeline

target ligase modality area discovery hit to lead preclinical
CBL-B Inhibition Immuno-oncology
E3 Ligase Inhibition Immuno-oncology
target ligase modality area discovery hit to lead preclinical
BTK Chimeric Targeting Molecule Hematology / Oncology
Undisclosed Chimeric Targeting Molecule Hematology / Oncology

target / modality / area phase
CBL-B
Inhibition
Immuno-oncology
preclinical
E3 Ligase
Inhibition
Immuno-oncology
hit to lead

+
target / modality / area phase
BTK
Chimeric Targeting Molecule
Hematology / Oncology
preclinical
Undisclosed
Chimeric Targeting Molecule
Hematology / Oncology
hit to lead